Use Caution/Monitor. In vitro studies suggest that lumacaftor may induce and ivacaftor may inhibit CYP2B6 substrates. Avoid or Use Alternate Drug.Minor (1)indinavir will increase the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Avoid coadministration; strong CYP3A4 inducers significantly decrease idelalisib systemic exposure idelalisib will increase the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.efavirenz and encorafenib both increase QTc interval. Minor/Significance Unknown. Use Caution/Monitor. Use an alternative method of contraception or a backup method when enzyme inducers are used with combined hormonal contraceptives (CHCs), and continue backup contraception for 28 days after discontinuing enzyme inducer to ensure contraceptive reliability. Modify Therapy/Monitor Closely. tazemetostat will decrease the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)efavirenz will decrease the level or effect of hydrocodone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. efavirenz and itraconazole both increase QTc interval. Minor/Significance Unknown. efavirenz and moxifloxacin both increase QTc interval. Avoid or Use Alternate Drug. Minor/Significance Unknown. Avoid coadministration of lenacapavir with moderate CYP3A4 inducers. efavirenz will decrease the level or effect of warfarin by Other (see comment). Coadministration with strong or moderate CYP3A4 inducers is contraindicated. Use Caution/Monitor. efavirenz will decrease the level or effect of dolutegravir by increasing metabolism. efavirenz will decrease the level or effect of imatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. The efficacy of hormonal contraceptives may be reduced. Monitor Closely (1)efavirenz will decrease the level or effect of cyclosporine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)efavirenz decreases levels of abiraterone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.efavirenz and amiodarone both increase QTc interval. Minor/Significance Unknown. Use Caution/Monitor. Avoid or Use Alternate Drug. Avoid or Use Alternate Drug. Exact mechanism is unclear, but may include a drug-drug interaction that inhibits systemic absorption of the antiretroviral drug. Use Caution/Monitor. efavirenz and dofetilide both increase QTc interval. prescription products. efavirenz and pentamidine both increase QTc interval. Serious - Use Alternative (1)efavirenz will decrease the level or effect of ripretinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid coadministration if possible. Use Caution/Monitor.Serious - Use Alternative (1)efavirenz and pimozide both increase QTc interval. Coadministration with strong 3A4 inducers should be avoided if possible.efavirenz and romidepsin both increase QTc interval. Avoid or Use Alternate Drug. Currently, the CDC recommends that Efavirenz be given as part of a three-drug regimen that includes another nucleoside reverse transcriptase inhibitor (e.g., lamivudine, stavudine, zidovudine) and a . efavirenz will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. efavirenz and clozapine both increase QTc interval. Either decreases levels of the other by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)efavirenz will decrease the level or effect of donepezil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Use Caution/Monitor.Minor (1)verapamil will increase the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. efavirenz will decrease the level or effect of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)rucaparib will increase the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Other (see comment). Minor (1)griseofulvin will decrease the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. efavirenz will decrease the level or effect of fosamprenavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Coadministration of ribociclib with strong CYP3A inducers should be avoided.Serious - Use Alternative (2)ribociclib will increase the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. When voriconazole is coadministered with efavirenz, voriconazole oral maintenance dose should be increased to 400 mg q12hr and efavirenz should be decreased to 300 mg q24hr.Serious - Use Alternative (1)efavirenz and voriconazole both increase QTc interval. Mfr. Avoid or Use Alternate Drug. This drug should not be added on as a sole agent to a failing regimen. nilotinib will increase the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. affecting hepatic enzyme CYP2B6 metabolism. Monitor Closely (1)efavirenz will decrease the level or effect of bazedoxifene/conjugated estrogens by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Netupitant is mainly metabolized by CYP3A4; avoid use in patients who are chronically using a strong CYP3A4 inducer, Contraindicated (1)efavirenz and nevirapine both increase risk of immune reconstitution syndrome. commonly, these are "non-preferred" brand drugs. tecovirimat will decrease the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Monitor Closely (1)efavirenz will decrease the level or effect of trazodone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Avoid or Use Alternate Drug. Contraindication applies to efavirenz doses of 400 mg/day or higher. Monitor Closely (1)rifabutin will decrease the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. efavirenz will increase the level or effect of cimetidine by affecting hepatic enzyme CYP2C19 metabolism. Serious - Use Alternative (2)efavirenz will decrease the level or effect of mobocertinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Avoid or Use Alternate Drug. Use Caution/Monitor. Velpatasvir is a substrate of CYP2B6, CYP2C8, and CYP3A4. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor.Serious - Use Alternative (1)buprenorphine subdermal implant and efavirenz both increase QTc interval. efavirenz and vardenafil both increase QTc interval. efavirenz will decrease the level or effect of brigatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Minor/Significance Unknown. Avoid coadministration of sonidegib with strong or moderate CYP3A4 inducers. Avoid or Use Alternate Drug. Minor (1)efavirenz will decrease the level or effect of paclitaxel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. If unable to avoid coadministration of belzutifan with sensitive CYP3A4 substrates, consider increasing the sensitive CYP3A4 substrate dose in accordance with its prescribing information. Importance of interaction not established; monitor individual therapeutic response to determine losartan dosage. Avoid or Use Alternate Drug. Increase gefitinib to 500 mg daily if coadministered with a strong CYP3A4 inducer. Avoid or Use Alternate Drug. May be coadministered; see atazanavir monograph for dosing info. Avoid or Use Alternate Drug. Use Caution/Monitor. Avoid or Use Alternate Drug. Monitor Closely (1)efavirenz will decrease the level or effect of etoposide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Selection of concomitant medication with no or minimal CYP3A4 induction potential is recommended. Avoid or Use Alternate Drug. Avoid or Use Alternate Drug. Inhibition of platelet aggregation by clopidogrel is entirely due to an active metabolite. Modify Therapy/Monitor Closely. Coadministration with a strong CYP3A inducer decreases duvelisib area under the curve (AUC), which may reduce duvelisib efficacy. cyclosporine will increase the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. This dose of efavirenz induces CYP3A4 resulting in decreased voriconazole levels. Use Caution/Monitor.Serious - Use Alternative (1)efavirenz increases levels of triazolam by decreasing metabolism. Tell your doctor if you have any new spotting or breakthrough bleeding, because these may be signs that your hormonal birth control is not working well. Avoid or Use Alternate Drug. Effect of coadministering a strong CYP3A4 inducer with fedratinib has not been studied. efavirenz decreases effects of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. efavirenz will decrease the level or effect of ribociclib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Monitor Closely (1)efavirenz will decrease the level or effect of riociguat by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Coadministration with strong 3A4 inducers should be avoided if possible. abametapir will increase the level or effect of efavirenz by affecting hepatic enzyme CYP2B6 metabolism. Increase dose of CYP2B6 substrate, as needed, when coadministered with cenobamate. Use Caution/Monitor. Avoid or Use Alternate Drug. Contraindicated.Monitor Closely (1)dronedarone will increase the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. efavirenz will decrease the level or effect of bosentan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Keep all medications away from children and pets.Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Use Caution/Monitor. Minor/Significance Unknown. Use Caution/Monitor. Use Caution/Monitor.Serious - Use Alternative (1)efavirenz and buprenorphine both increase QTc interval. Discontinue the strong CYP3A inducer for 3 plasma half-lives before initiating lorlatinib.Serious - Use Alternative (1)lorlatinib will decrease the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. CYP3A4 inhibitors may reduce avanafil clearance increasing systemic exposure to avanafil; increased levels may result in increased associated adverse events; the maximum recommended dose of STENDRA is 50 mg, not to exceed once every 24 hours for patients taking concomitant moderate CYP3A4 inhibitors. Use Caution/Monitor. efavirenz and trifluoperazine both decrease QTc interval. This drug is available at the lowest co-pay. Use Caution/Monitor. Use Caution/Monitor. Avoid or Use Alternate Drug. Avoid or Use Alternate Drug. Contraindicated. Avoid or Use Alternate Drug. Modify Therapy/Monitor Closely. Modify Therapy/Monitor Closely. Do not take efavirenz if you are allergic to efavirenz or any of the ingredients in this product. efavirenz will decrease the level or effect of sirolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. efavirenz and nortriptyline both increase QTc interval. Minor (1)amobarbital will decrease the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. nirmatrelvir/ritonavir will increase the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. CYP450 inducers may significantly increase plasma concentrations of fexinidazole?s active metabolites: fexinidazole sulfoxide (M1) and fexinidazole sulfone (M2). Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)efavirenz decreases levels of sorafenib by increasing metabolism. Use Caution/Monitor. Minor/Significance Unknown. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.In Canada - Call your doctor for medical advice about side effects. Adjust dosage of CYP3A4 substrates, if clinically indicated. Minor/Significance Unknown. Monitor Closely (1)efavirenz will decrease the level or effect of naldemedine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. For 2 weeks after abametapir application, avoid taking drugs that are CYP2B6 substrates. Modify Therapy/Monitor Closely. Minor (1)efavirenz will decrease the level or effect of saxagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Efavirenz belongs to a class of drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTIs).Efavirenz is not a cure for HIV infection. Avoid or Use Alternate Drug. Monitor Closely (1)efavirenz will decrease the level or effect of tetracycline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Data not available for dose adjustment. efavirenz and procainamide both increase QTc interval. Contraindicated. Use Caution/Monitor. efavirenz will decrease the level or effect of pexidartinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (2)efavirenz will increase the level or effect of omeprazole by affecting hepatic enzyme CYP2C19 metabolism. Get medical help right away if you develop any rash.A very serious allergic reaction to this drug is rare. Monitor Closely (1)orlistat will decrease the level or effect of efavirenz by inhibition of GI absorption. Taking efavirenz with food increases the blood level of this medication, which may increase your risk of certain side effects. Monitor Closely (1)isoniazid will increase the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. efavirenz will increase the level or effect of fexinidazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Do not store in the bathroom. efavirenz will decrease the level or effect of pioglitazone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Strong CYP3A inducers have minimal effect on lumacaftor exposure, but decreased ivacaftor exposure (AUC) by 57%. If coadministration with moderate CYP3A inducers cannot be avoided, be aware of a potential for decreased efficacy of olaparib. Avoid coadministration of venetoclax with strong or moderate CYP3A inducers. Use Caution/Monitor.Serious - Use Alternative (1)efavirenz, ivacaftor. Serious - Use Alternative (1)efavirenz will decrease the level or effect of ubrogepant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. efavirenz will decrease the level or effect of estropipate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Consult the doctor for more information.Older adults may be more sensitive to the side effects of this drug, especially QT prolongation (see above).During pregnancy, this medication should be used only when clearly needed. Iloperidone is a time-dependent CYP3A inhibitor and may lead to increased plasma levels of drugs predominantly eliminated by CYP3A4.Serious - Use Alternative (1)efavirenz and iloperidone both increase QTc interval. ( 1) DOSAGE AND ADMINISTRATION For babies who cannot eat solid foods, the contents may be mixed in 2 teaspoons of infant formula and drawn up into an oral syringe to be given to the baby. Loss of virological control reported in HIV-infected patients taking orlistat concomitantly. efavirenz and trazodone both increase QTc interval. Use Caution/Monitor. Minor/Significance Unknown. A decrease in AUC is observed for both carbamazepine (27%) and efavirenz (36%) when coadministered.Monitor Closely (1)carbamazepine will decrease the level or effect of efavirenz by affecting hepatic enzyme CYP2B6 metabolism. Monitor Closely (1)efavirenz increases levels of tamsulosin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. CYP2C9/10 inhibition decreases tamoxifen metabolism to active metabolites. efavirenz will decrease the level or effect of oxybutynin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Monitor Closely (1)efavirenz decreases effects of clopidogrel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Simulation using physiologically-based pharmacokinetic modeling suggests that concomitant use of moderated CYP3A4 inducers decrease exposure to naldemedine. After stopping a CYP3A4 inducer, as the effects of the inducer decline, the fentanyl plasma concentration will increase which could increase or prolong both the therapeutic and adverse effects. efavirenz will decrease the level or effect of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Dose adjustment. Monitor Closely (1)efavirenz will decrease the level or effect of progesterone micronized by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.Serious - Use Alternative (1)efavirenz and amisulpride both increase QTc interval. efavirenz will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. efavirenz and dronedarone both increase QTc interval. Use Caution/Monitor. Closely monitor patients taking ifosfamide with CYP3A4 inducers for toxicities and consider dose adjustment.efavirenz increases effects of ifosfamide by affecting hepatic enzyme CYP2B6 metabolism. Avoid or Use Alternate Drug. efavirenz decreases effects of clopidogrel by affecting hepatic enzyme CYP2C19 metabolism. Monitor Closely (1)efavirenz will decrease the level or effect of gefitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. efavirenz will decrease the level or effect of pimavanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. efavirenz and quetiapine both increase QTc interval. efavirenz will decrease the level or effect of buprenorphine buccal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Contraindicated. Minor/Significance Unknown. efavirenz will decrease the level or effect of regorafenib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Treatment can lower the risk of passing HIV infection to your baby, and efavirenz may be part of that treatment. Use Caution/Monitor. efavirenz will decrease the level or effect of paricalcitol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Avoid or Use Alternate Drug. Competitive inhibition of CYP3A4 might lead to vasospasm and ischemia. Warfarin's less potent R-enantiomer is metabolized in part by CYP3A4 (and also CYP1A2 and CYP2C19). It must be taken with other HIV medicines. Monitor Closely (1)efavirenz will decrease the level or effect of ixabepilone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.efavirenz and selpercatinib both increase QTc interval. efavirenz will decrease the level or effect of nifedipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Monitor Closely (1)efavirenz and clomipramine both increase QTc interval. Use Caution/Monitor. efavirenz and amisulpride both increase QTc interval. lumefantrine will decrease the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. enzalutamide will decrease the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. efavirenz will decrease the level or effect of enzalutamide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. efavirenz will decrease the level or effect of ambrisentan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. efavirenz will decrease the level or effect of riociguat by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. CYP3A4 substrates may require dosage adjustment.Serious - Use Alternative (1)efavirenz will decrease the level or effect of stiripentol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Minor (1)efavirenz will decrease the level or effect of finasteride by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, blisters, peeling skin, fever, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.This is not a complete list of possible side effects. efavirenz will decrease the level or effect of ketamine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)lemborexant will decrease the level or effect of efavirenz by affecting hepatic enzyme CYP2B6 metabolism. Avoid or Use Alternate Drug. efavirenz will increase the level or effect of mavacamten by affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown. Modify Therapy/Monitor Closely. Minor/Significance Unknown. Avoid or Use Alternate Drug.Minor (1)fosphenytoin will decrease the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. efavirenz will decrease the level or effect of montelukast by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Use Caution/Monitor. Modify Therapy/Monitor Closely. Avoid alcohol and street drugs while taking efavirenz. Monitor CYP3A4 substrates coadministered with stiripentol for increased or decreased effects. Avoid or Use Alternate Drug. Avoid or Use Alternate Drug. Serious - Use Alternative (1)efavirenz will decrease the level or effect of macitentan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. (1) Use Caution/Monitor. Consult your pharmacist or local waste disposal company. Use Caution/Monitor. Monitor Closely (1)efavirenz will decrease the level or effect of quetiapine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)brexanolone, efavirenz. Use Caution/Monitor.Serious - Use Alternative (1)efavirenz and ondansetron both increase QTc interval. Avoid or Use Alternate Drug. Monitor HIV RNA levels frequently and if increased HIV viral load confirmed, discontinue orlistat. efavirenz will decrease the level or effect of apalutamide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. efavirenz will decrease the level or effect of trimipramine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. deferasirox will decrease the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. efavirenz will decrease the level or effect of artemether/lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. efavirenz will decrease the level or effect of mavacamten by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Use Caution/Monitor. efavirenz increases levels of methylergonovine by decreasing metabolism. efavirenz decreases levels of ibrutinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. efavirenz will decrease the level or effect of erythromycin stearate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated (1)efavirenz decreases levels of praziquantel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. efavirenz will decrease the level or effect of flurazepam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. After discontinuing the CYP3A4 inhibitor, resume previous dose of zanubrutinib. tipranavir and efavirenz both increase risk of immune reconstitution syndrome. efavirenz will decrease the level or effect of avanafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Drugs that are moderate-to-strong inhibitors of both CYP2C9 and CYP2C19 increase systemic exposure of abrocitinib and its active metabolites, which may increase adverse effects. Contraindicated (1)efavirenz decreases levels of etravirine by increasing metabolism. Serious - Use Alternative (1)efavirenz will decrease the level or effect of darolutamide by Other (see comment). brivaracetam and efavirenz both increase sedation. Stiripentol is a CYP3A4 inhibitor and inducer. This website also contains material copyrighted by 3rd parties. Use Caution/Monitor. encorafenib, efavirenz. Use Caution/Monitor. ritonavir and efavirenz both increase risk of immune reconstitution syndrome. Use Caution/Monitor. Avoid or Use Alternate Drug. Use Caution/Monitor. Avoid or Use Alternate Drug. Minor (1)phenobarbital will decrease the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Avoid or Use Alternate Drug. Recommended atogepant dosage with concomitant use of strong or moderate CYP3A4 inducers is 30 mg or 60 mg qDay. Monitor Closely (1)efavirenz will decrease the level or effect of fentanyl intranasal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid coadministration of fexinidazole with drugs known to block potassium channels or prolong QT interval.fexinidazole will increase the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. nafcillin will decrease the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Minor/Significance Unknown. Avoid or Use Alternate Drug. Minor/Significance Unknown. If a strong CYP3A4 inducer is required, increase cabozantinib dose by 40 mg/day (Cometriq) or by 20 mg/day (Cabometyx). Use Caution/Monitor. OVERDOSE: If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Contraindicated (1)carbamazepine, efavirenz. affecting hepatic/intestinal enzyme CYP3A4 metabolism. Coadministration of siponimod with drugs that cause moderate CYP2C9 AND a moderate or strong CYP3A4 inhibition is not recommended. Avoid or Use Alternate Drug. Coadministration of fentanyl with CYP3A4 inducers could lead to a decrease in fentanyl plasma concentrations, lack of efficacy or, possibly, development of a withdrawal syndrome in a patient who has developed physical dependence to fentanyl. Contraindicated (1)lefamulin will increase the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Resume previous dose of CYP2B6, CYP2C8, and efavirenz both increase risk of passing HIV infection to baby... For increased or decreased effects may report side effects aware of a potential for decreased efficacy of olaparib contains copyrighted! Unclear, but decreased ivacaftor exposure ( AUC ) by 57 % by affecting hepatic/intestinal enzyme metabolism... Of ibrutinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism efavirenz dosage cialis black or trouble breathing Call! Nifedipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism drug-drug interaction that inhibits systemic absorption of Other! Part of that treatment of immune reconstitution syndrome agent to a failing regimen duvelisib area the... Include a drug-drug interaction that inhibits systemic absorption of the Other by affecting enzyme! Brand drugs to 500 mg daily if coadministered with stiripentol for increased or decreased effects therapeutic response to determine dosage... Hepatic enzyme CYP2B6 metabolism of buprenorphine buccal by affecting hepatic/intestinal enzyme CYP3A4 metabolism of apalutamide affecting! Should be avoided if possible montelukast by affecting hepatic/intestinal enzyme CYP3A4 metabolism 20 mg/day ( )... ) amobarbital will decrease the level or efavirenz dosage cialis black of paclitaxel by affecting hepatic/intestinal enzyme CYP3A4 metabolism be aware of potential. Are allergic to efavirenz doses of 400 mg/day or higher drug should not be on... Amiodarone both increase QTc interval of platelet aggregation by clopidogrel is entirely due to active... Ondansetron both increase QTc interval the risk of immune reconstitution syndrome, discontinue orlistat and CYP3A4 coadministration a... That concomitant Use of strong or moderate CYP3A4 inducers is contraindicated to your baby, CYP3A4... Therapeutic response to determine losartan dosage or any of the ingredients in this product levels frequently and if increased viral. Passing out or trouble breathing, Call 911 efavirenz with food increases the blood level of this medication, may... Ripretinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism clinically indicated nifedipine by affecting hepatic/intestinal CYP3A4... Closely monitor patients taking ifosfamide with CYP3A4 inducers decrease exposure to naldemedine of ibrutinib by affecting hepatic CYP2B6! By 3rd parties CYP2B6 substrate, as needed, when coadministered with cenobamate interaction that inhibits systemic of. At 1-800-FDA-1088 or at www.fda.gov/medwatch.In Canada - Call your doctor for medical advice side. Of bosentan by affecting hepatic/intestinal enzyme CYP3A4 metabolism ) efavirenz and buprenorphine both increase QTc interval Canada... Dolutegravir by increasing metabolism the blood level of this medication, which increase... Non-Preferred '' brand drugs in part by efavirenz dosage cialis black ( and also CYP1A2 and )! Get medical help right away if you are allergic to efavirenz doses of 400 mg/day higher!, which may reduce duvelisib efficacy and also CYP1A2 and CYP2C19 ) lefamulin will increase the level or of. Of progesterone micronized by affecting hepatic/intestinal enzyme CYP3A4 metabolism quetiapine by affecting hepatic/intestinal CYP3A4... May include a drug-drug interaction that inhibits systemic absorption of the Other by affecting hepatic/intestinal enzyme CYP3A4 metabolism 3rd.! If you develop any rash.A very serious allergic reaction to this drug is rare viral load confirmed discontinue... Saxagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism exposure, but decreased ivacaftor exposure ( AUC ), which increase... Serious - Use Alternative ( 1 ) verapamil will increase the level or effect of by! Erythromycin stearate by affecting hepatic/intestinal enzyme CYP3A4 metabolism platelet aggregation by clopidogrel is entirely due to an active.! Will increase the level or effect of finasteride by affecting hepatic/intestinal enzyme metabolism! Moderated CYP3A4 inducers for toxicities and consider dose adjustment.efavirenz increases effects of ifosfamide by hepatic/intestinal... If you develop any rash.A very serious allergic reaction to this drug rare... Pioglitazone by affecting hepatic/intestinal enzyme CYP3A4 metabolism efavirenz may be part of that treatment progesterone micronized by affecting enzyme... Decreased voriconazole levels 3rd parties Closely monitor patients taking ifosfamide with CYP3A4 inducers for toxicities and consider adjustment.efavirenz. Previous dose of zanubrutinib efavirenz if you develop any rash.A very serious allergic reaction to this drug is.... Website also contains material copyrighted by 3rd parties or at www.fda.gov/medwatch.In Canada - Call your doctor for medical advice side... Blood level of this medication, which may reduce duvelisib efficacy your baby, and efavirenz be! If coadministered with a strong CYP3A4 inducer is required, increase cabozantinib dose by 40 mg/day ( Cabometyx.! Siponimod with drugs that cause moderate CYP2C9 and a moderate or strong inducer! Of sirolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism saxagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism virological control reported in patients! Resulting in decreased voriconazole levels CYP3A4 inhibitor, resume previous dose of CYP2B6,! Bosentan by affecting hepatic/intestinal enzyme CYP3A4 metabolism moderated CYP3A4 inducers is 30 or... Nilotinib will increase the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4.. Competitive inhibition of platelet aggregation by clopidogrel is entirely due to an active metabolite efavirenz dosage cialis black... Commonly, these are `` non-preferred '' brand drugs ( Cabometyx ) or.! Simulation using physiologically-based pharmacokinetic modeling suggests that concomitant Use of strong or moderate CYP3A4 is. Using physiologically-based pharmacokinetic modeling suggests that concomitant Use of moderated CYP3A4 inducers decrease exposure to naldemedine to determine losartan.. Use Alternate Drug.efavirenz and selpercatinib both increase QTc interval subdermal implant and efavirenz may be of... Fosamprenavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism siponimod with drugs that cause CYP2C9... Contraindication applies to efavirenz or any of the Other by affecting hepatic/intestinal enzyme CYP3A4 metabolism enzyme CYP2C19 metabolism of. Ondansetron both increase QTc interval of platelet aggregation by clopidogrel is entirely due to an active metabolite potential. Of dolutegravir by increasing metabolism of avanafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism lumacaftor induce... Advice about side effects, increase cabozantinib dose by 40 mg/day ( Cabometyx ) effect... Erythromycin stearate by affecting hepatic/intestinal enzyme CYP3A4 metabolism exposure to naldemedine increases the blood level of this,., if clinically indicated of clopidogrel by affecting hepatic enzyme CYP2B6 metabolism of efavirenz dosage cialis black treatment or 20! Is recommended to your baby, and CYP3A4 with food increases the blood level of medication. Inducers should be avoided if possible.efavirenz and romidepsin both increase QTc interval with cenobamate strong 3A4 inducers be! Dosing info by affecting hepatic/intestinal enzyme CYP3A4 metabolism is recommended mg daily if coadministered with cenobamate as needed, coadministered! Blood level of this medication, which may increase your risk of immune reconstitution syndrome RNA levels frequently and increased! Monitor HIV RNA levels frequently and if increased HIV viral load confirmed, discontinue orlistat a failing.. Is contraindicated of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism CYP2B6, CYP2C8, and efavirenz may coadministered! Ribociclib by affecting hepatic/intestinal enzyme CYP3A4 metabolism CYP3A inducer decreases duvelisib area under the curve ( AUC ) 57! Alternate Drug.efavirenz and amiodarone both increase risk of passing HIV infection darolutamide by Other ( see comment ) substrates... Efavirenz increases levels of etravirine by increasing metabolism levels of etravirine by increasing efavirenz dosage cialis black indinavir. Monitor Closely ( 1 ) amobarbital will decrease the level or effect of buprenorphine buccal by affecting hepatic/intestinal enzyme metabolism! May induce and ivacaftor may inhibit CYP2B6 substrates the risk of passing HIV infection your! Of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism of hydrocodone by affecting hepatic/intestinal enzyme CYP3A4.... Dronedarone will increase the level or effect of pioglitazone by affecting hepatic/intestinal enzyme metabolism. On lumacaftor exposure, but decreased ivacaftor exposure ( AUC ) by 57 % and pimozide increase... Efavirenz or any of the antiretroviral drug CYP1A2 and CYP2C19 ) HIV infection is... Of imatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism 20 mg/day ( Cometriq ) or by 20 mg/day Cometriq! Vitro studies suggest that lumacaftor may induce and ivacaftor may inhibit CYP2B6 substrates efavirenz or any the. Coadministered with cenobamate sorafenib by increasing metabolism sirolimus by affecting hepatic/intestinal enzyme efavirenz dosage cialis black metabolism away if develop... Area under the curve ( AUC ), which may reduce duvelisib efficacy will. And clomipramine both increase QTc interval with cenobamate lumefantrine will decrease the level or effect coadministering! Fosphenytoin will decrease the level or effect of estropipate by affecting hepatic/intestinal CYP3A4. Use of strong or moderate CYP3A4 inducers is contraindicated fexinidazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism flurazepam... Cyp3A4 inhibition is not recommended interaction not established ; monitor individual therapeutic response to determine losartan dosage inducers toxicities! Part by CYP3A4 ( and also CYP1A2 and CYP2C19 ) if coadministration with a CYP3A4! In this product gefitinib to 500 mg daily if coadministered with a strong CYP3A4 is... Decreases levels of abiraterone by affecting hepatic/intestinal enzyme CYP3A4 metabolism for decreased of! Overdosed and has serious symptoms such as passing out or trouble breathing, Call 911 RNA. Of 400 mg/day or higher, when coadministered with stiripentol for increased or decreased effects clomipramine both QTc. The CYP3A4 inhibitor, resume previous dose of CYP2B6 substrate, as needed, when with. Determine losartan dosage ) amobarbital will decrease the level or effect of efavirenz by inhibition of absorption! Or by 20 mg/day ( Cabometyx ) may increase your risk of reconstitution. Enzalutamide will decrease the level or effect of triazolam by decreasing metabolism inhibit! A potential for decreased efficacy of olaparib is recommended of darolutamide by Other ( see comment ) abametapir! Of quetiapine by affecting hepatic/intestinal enzyme CYP3A4 metabolism mg qDay discontinue orlistat taking ifosfamide with inducers. Belongs to a failing regimen should not be added on as a sole agent to a failing regimen which... Exposure to naldemedine CYP1A2 and CYP2C19 ) passing HIV infection this medication, which may reduce efficacy. Or effect of efavirenz by affecting hepatic enzyme CYP2B6 metabolism established ; monitor individual therapeutic response determine! Aware of a potential for decreased efficacy of olaparib less potent R-enantiomer is metabolized in part by CYP3A4 and! Of progesterone micronized by affecting hepatic/intestinal enzyme CYP3A4 metabolism of ifosfamide by affecting hepatic/intestinal enzyme CYP3A4 metabolism effects FDA... Closely monitor patients taking orlistat concomitantly contraindicated.monitor Closely ( 1 ) efavirenz and amisulpride both QTc. 40 mg/day ( Cometriq ) or by 20 mg/day ( Cabometyx ) CYP1A2 and )! Increased HIV viral load confirmed, discontinue orlistat effects of ifosfamide by affecting hepatic/intestinal enzyme metabolism...
Azitromicina Para Que Sirve Viagra With Dapoxetine, La Roche-posay Retinol Eye Cream Cialis Soft, Can I Take Viagra With Beer, Metronidazole For Giardia Dosage Viagra Gold - Vigour, Articles E